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Mesoporous silicon and silica-based particles have recently been synthesized and proposed for 
the controlled delivery of several drugs [1,2]. On the other hand, nature and in particular marine 
organisms have been the source and inspiration for the development of different biomedical 
applications, including drug delivery devices [3]. On the border of both rests diatoms 
exoskeletons, nature-made porous silica-based microparticles with amazing morphological 
features, promising a high potential in drug delivery. Nevertheless, its safety and drug 
permeability on oral formulations have not yet been studied. In this study, we have demonstrated 
that diatoms silica microparticles (DSM) have almost no toxicity in colon cancer cells Caco-2, HT-
29, HCT-116 and Caco-2/HT-29, even at concentrations as high as 1000 µg/mL. Moreover, the 
delivery profile of two common drugs to address gastrointestinal diseases, mesalamine (anti-
inflammatory) and prednisone (glucocorticosteroid). DSMs are able to release prednisone in a 
controlled manner and change its absorption pattern, which may improve the safety of its 
administration. In addition, DSMs can enhance the permeation of mesalamine. These results 
confirm the potential of DSMs for the development of oral formulations for the therapy of 
gastrointestinal diseases. 
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